§ Funding Round
EpimAb Biotherapeutics raised $74M Series B venture round, led by dongfang li.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
dongfang liLEAD | Angel | dongfang li |
cheng xingLEAD | Angel | cheng xing |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$219M
Top Valuation
-
EpimAb Biotherapeutics raised $74M in a Series B round.
The round was announced on 06/05/19.
The round was led by dongfang li, cheng xing.
